NFKB1 and diffuse large B-cell lymphoma: This study found WEE1, a replication checkpoint kinase that arrests cells at the G2/M checkpoint to give time for DNA repair, and PARP1, a repairing protein involved in high genomic instability and NF-kB activation, as potential candidates for DLBCL treatments.